Use of Granulocyte Colony-Stimulating Factor Following Hematopoietic Cell Transplantation: Does Haste Make Waste?
- 1 February 2004
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (3) , 390-391
- https://doi.org/10.1200/jco.2004.11.963
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Treatment With Granulocyte Colony-Stimulating Factor After Allogeneic Bone Marrow Transplantation for Acute Leukemia Increases the Risk of Graft-Versus-Host Disease and Death: A Study From the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationJournal of Clinical Oncology, 2004
- The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysisBone Marrow Transplantation, 2003
- Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen–matched related donorsBlood, 2001
- Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantationBone Marrow Transplantation, 2001
- Administration of recombinant human granulocyte-macrophage colony-stimulating factor to children undergoing allogeneic marrow transplantation: A prospective, randomized, double-masked,placebo-controlled trialPediatric Transplantation, 2000
- Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donorsBone Marrow Transplantation, 1999
- Granulocyte-colony-stimulating factor after allogeneic and autologous bone marrow transplantation in childrenMedical and Pediatric Oncology, 1996
- Granulocyte colony-stimulating factor after allogeneic bone marrow transplantationBlood, 1994
- Placebo-controlled phase III trial of lenograstim in bone-marrow transplantationThe Lancet, 1994
- Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trialThe Lancet, 1990